Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bronchopulmonary Dysplasia | 13 | 2022 | 316 | 2.800 |
Why?
|
Neonatal Screening | 29 | 2024 | 594 | 2.730 |
Why?
|
Cystic Fibrosis | 29 | 2022 | 1274 | 2.560 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 16 | 2019 | 446 | 1.510 |
Why?
|
Uteroglobin | 2 | 2022 | 56 | 1.460 |
Why?
|
Genetic Counseling | 6 | 2022 | 624 | 1.230 |
Why?
|
Respiratory Distress Syndrome, Newborn | 6 | 2019 | 227 | 1.050 |
Why?
|
Infant, Newborn | 73 | 2024 | 26176 | 0.910 |
Why?
|
Genetic Testing | 18 | 2023 | 3529 | 0.740 |
Why?
|
Infant, Premature, Diseases | 9 | 2019 | 709 | 0.720 |
Why?
|
Infant, Premature | 11 | 2021 | 2094 | 0.700 |
Why?
|
Insurance | 1 | 2021 | 113 | 0.660 |
Why?
|
Twin Studies as Topic | 1 | 2018 | 104 | 0.620 |
Why?
|
Dinucleotide Repeats | 1 | 2016 | 29 | 0.550 |
Why?
|
Gestational Age | 13 | 2022 | 3565 | 0.550 |
Why?
|
Superoxide Dismutase | 5 | 2012 | 592 | 0.510 |
Why?
|
Lung Diseases | 4 | 2019 | 1908 | 0.500 |
Why?
|
Sweat | 6 | 2011 | 56 | 0.470 |
Why?
|
Trypsinogen | 6 | 2011 | 84 | 0.470 |
Why?
|
Neurotoxicity Syndromes | 1 | 2018 | 300 | 0.450 |
Why?
|
Enterocolitis, Necrotizing | 3 | 2021 | 326 | 0.420 |
Why?
|
Anesthetics | 1 | 2018 | 522 | 0.410 |
Why?
|
Neonatology | 1 | 2014 | 140 | 0.400 |
Why?
|
Chlorides | 6 | 2011 | 663 | 0.390 |
Why?
|
Fetus | 2 | 2018 | 1860 | 0.380 |
Why?
|
DNA Mutational Analysis | 9 | 2011 | 4107 | 0.380 |
Why?
|
Retinopathy of Prematurity | 2 | 2013 | 432 | 0.370 |
Why?
|
Oxygen Inhalation Therapy | 2 | 2012 | 399 | 0.360 |
Why?
|
Medical Staff, Hospital | 1 | 2014 | 600 | 0.350 |
Why?
|
Epithelial Cells | 1 | 2022 | 3664 | 0.350 |
Why?
|
Hypnotics and Sedatives | 1 | 2018 | 1176 | 0.340 |
Why?
|
High-Frequency Ventilation | 1 | 2010 | 88 | 0.340 |
Why?
|
Parents | 7 | 2022 | 3548 | 0.330 |
Why?
|
Pseudomonas Infections | 2 | 2006 | 621 | 0.320 |
Why?
|
Cause of Death | 1 | 2018 | 3667 | 0.300 |
Why?
|
Respiration, Artificial | 7 | 2013 | 2619 | 0.290 |
Why?
|
Infant | 18 | 2024 | 36045 | 0.260 |
Why?
|
Iontophoresis | 1 | 2005 | 74 | 0.260 |
Why?
|
Genetic Predisposition to Disease | 7 | 2021 | 17767 | 0.240 |
Why?
|
Ultrasonography, Prenatal | 8 | 2013 | 1744 | 0.240 |
Why?
|
Antioxidants | 1 | 2012 | 1665 | 0.230 |
Why?
|
Diagnostic Imaging | 1 | 2018 | 3524 | 0.220 |
Why?
|
Immunoassay | 2 | 2010 | 746 | 0.210 |
Why?
|
Fetal Diseases | 6 | 2019 | 911 | 0.210 |
Why?
|
Pulmonary Surfactants | 4 | 2019 | 161 | 0.200 |
Why?
|
Genomics | 5 | 2023 | 5788 | 0.200 |
Why?
|
Internet | 1 | 2014 | 3081 | 0.200 |
Why?
|
Clubfoot | 2 | 2013 | 87 | 0.190 |
Why?
|
Child Development | 5 | 2012 | 2286 | 0.180 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2024 | 268 | 0.180 |
Why?
|
Humans | 91 | 2024 | 757566 | 0.180 |
Why?
|
Attitude of Health Personnel | 2 | 2014 | 3864 | 0.180 |
Why?
|
Body Fluids | 1 | 2022 | 319 | 0.170 |
Why?
|
Genome, Human | 3 | 2023 | 4414 | 0.160 |
Why?
|
Infant Care | 2 | 2012 | 180 | 0.160 |
Why?
|
Infant, Newborn, Diseases | 2 | 2021 | 591 | 0.160 |
Why?
|
False Positive Reactions | 5 | 2013 | 956 | 0.160 |
Why?
|
Biotinidase | 1 | 2018 | 17 | 0.160 |
Why?
|
Recombinant Proteins | 6 | 2019 | 6525 | 0.160 |
Why?
|
Sequence Analysis, DNA | 3 | 2019 | 4710 | 0.160 |
Why?
|
Endotoxins | 2 | 2012 | 521 | 0.160 |
Why?
|
Intensive Care, Neonatal | 2 | 2010 | 198 | 0.150 |
Why?
|
Twins, Dizygotic | 1 | 2018 | 236 | 0.150 |
Why?
|
Intestinal Atresia | 2 | 1995 | 68 | 0.150 |
Why?
|
Fetal Growth Retardation | 2 | 2012 | 579 | 0.140 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2021 | 3480 | 0.140 |
Why?
|
Twins, Monozygotic | 1 | 2018 | 469 | 0.140 |
Why?
|
Radiography, Abdominal | 1 | 2020 | 532 | 0.140 |
Why?
|
Complement C1 Inactivator Proteins | 3 | 1992 | 92 | 0.130 |
Why?
|
Trachea | 3 | 2012 | 1082 | 0.130 |
Why?
|
Health | 1 | 2019 | 397 | 0.130 |
Why?
|
Mouth | 1 | 1998 | 380 | 0.130 |
Why?
|
International Classification of Diseases | 1 | 2021 | 891 | 0.130 |
Why?
|
Echo-Planar Imaging | 1 | 2019 | 657 | 0.120 |
Why?
|
Angioedema | 3 | 1992 | 192 | 0.120 |
Why?
|
California | 2 | 2016 | 1418 | 0.120 |
Why?
|
Ultrasonography | 5 | 2021 | 5951 | 0.120 |
Why?
|
False Negative Reactions | 2 | 2005 | 573 | 0.120 |
Why?
|
Algorithms | 7 | 2014 | 13952 | 0.110 |
Why?
|
Internship and Residency | 1 | 2014 | 5854 | 0.110 |
Why?
|
Female | 41 | 2024 | 389943 | 0.110 |
Why?
|
Boston | 2 | 2018 | 9298 | 0.110 |
Why?
|
Decision Trees | 2 | 2005 | 504 | 0.110 |
Why?
|
Ileum | 2 | 1999 | 556 | 0.110 |
Why?
|
Risk Factors | 11 | 2021 | 73708 | 0.110 |
Why?
|
Disease | 1 | 2019 | 671 | 0.110 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3614 | 0.110 |
Why?
|
Lung | 6 | 2019 | 9973 | 0.110 |
Why?
|
Infant, Very Low Birth Weight | 4 | 2009 | 406 | 0.110 |
Why?
|
Retrospective Studies | 14 | 2021 | 79984 | 0.100 |
Why?
|
Respiration | 1 | 2019 | 1654 | 0.100 |
Why?
|
Mutation | 9 | 2017 | 29929 | 0.100 |
Why?
|
Genetic Diseases, Inborn | 1 | 2017 | 601 | 0.100 |
Why?
|
Male | 32 | 2024 | 358180 | 0.100 |
Why?
|
Double-Blind Method | 2 | 2019 | 12261 | 0.100 |
Why?
|
S100 Proteins | 1 | 2012 | 218 | 0.100 |
Why?
|
Pregnancy | 12 | 2018 | 29712 | 0.100 |
Why?
|
Homozygote | 1 | 1996 | 1788 | 0.100 |
Why?
|
Computer-Assisted Instruction | 1 | 2014 | 362 | 0.090 |
Why?
|
Intestinal Obstruction | 1 | 1995 | 431 | 0.090 |
Why?
|
Soy Foods | 1 | 2010 | 44 | 0.090 |
Why?
|
Phytoestrogens | 1 | 2010 | 59 | 0.090 |
Why?
|
Massachusetts | 8 | 2010 | 8815 | 0.090 |
Why?
|
Patient Acceptance of Health Care | 2 | 2020 | 3165 | 0.090 |
Why?
|
Respiratory Function Tests | 1 | 2015 | 1680 | 0.090 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1795 | 0.080 |
Why?
|
Reference Values | 5 | 2009 | 4918 | 0.080 |
Why?
|
Prenatal Diagnosis | 1 | 2016 | 1264 | 0.080 |
Why?
|
Ethics, Medical | 1 | 2014 | 783 | 0.080 |
Why?
|
Immunity, Innate | 2 | 2012 | 3043 | 0.080 |
Why?
|
Chromosome Deletion | 2 | 1990 | 1387 | 0.080 |
Why?
|
Oropharynx | 1 | 2009 | 133 | 0.080 |
Why?
|
Foundations | 1 | 2008 | 94 | 0.080 |
Why?
|
Decision Making, Organizational | 2 | 2005 | 136 | 0.080 |
Why?
|
Alleles | 2 | 2016 | 6894 | 0.070 |
Why?
|
Testis | 1 | 2010 | 793 | 0.070 |
Why?
|
Risk Assessment | 5 | 2021 | 23816 | 0.070 |
Why?
|
Parenting | 2 | 2022 | 695 | 0.070 |
Why?
|
Ventilators, Mechanical | 1 | 2009 | 287 | 0.070 |
Why?
|
ROC Curve | 1 | 2015 | 3562 | 0.070 |
Why?
|
Genotype | 6 | 2014 | 12951 | 0.070 |
Why?
|
Genetic Association Studies | 1 | 2016 | 2717 | 0.070 |
Why?
|
Critical Illness | 1 | 2019 | 2705 | 0.070 |
Why?
|
Uterus | 1 | 2010 | 649 | 0.070 |
Why?
|
Heart Defects, Congenital | 2 | 2021 | 4673 | 0.070 |
Why?
|
Ovary | 1 | 2010 | 958 | 0.070 |
Why?
|
Age of Onset | 2 | 2019 | 3296 | 0.070 |
Why?
|
Chronic Disease | 3 | 2019 | 9263 | 0.070 |
Why?
|
Lysine | 1 | 1990 | 993 | 0.060 |
Why?
|
Death | 1 | 2010 | 674 | 0.060 |
Why?
|
Pilocarpine | 1 | 2005 | 64 | 0.060 |
Why?
|
Point Mutation | 2 | 2006 | 1594 | 0.060 |
Why?
|
Histidine | 1 | 2006 | 308 | 0.060 |
Why?
|
Fellowships and Scholarships | 1 | 2014 | 1113 | 0.060 |
Why?
|
Diffusion Tensor Imaging | 1 | 2016 | 2387 | 0.060 |
Why?
|
Pseudomonas aeruginosa | 2 | 2006 | 1275 | 0.060 |
Why?
|
Carrier State | 1 | 2009 | 525 | 0.060 |
Why?
|
Muscarinic Agonists | 1 | 2005 | 91 | 0.060 |
Why?
|
Reperfusion Injury | 1 | 1992 | 1023 | 0.060 |
Why?
|
Logistic Models | 4 | 2021 | 13221 | 0.060 |
Why?
|
Survival Rate | 2 | 2018 | 12684 | 0.060 |
Why?
|
Data Collection | 1 | 2014 | 3319 | 0.060 |
Why?
|
Patient Readmission | 1 | 2019 | 3241 | 0.060 |
Why?
|
Phenotype | 3 | 2019 | 16533 | 0.060 |
Why?
|
Cohort Studies | 2 | 2018 | 41190 | 0.060 |
Why?
|
Oxygen | 2 | 1992 | 4190 | 0.060 |
Why?
|
Patient Care Planning | 1 | 2009 | 906 | 0.060 |
Why?
|
Estrogens | 1 | 2010 | 1519 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2021 | 4760 | 0.060 |
Why?
|
Public Health | 1 | 2017 | 2658 | 0.060 |
Why?
|
Program Development | 2 | 2010 | 1296 | 0.050 |
Why?
|
Predictive Value of Tests | 6 | 2020 | 15207 | 0.050 |
Why?
|
Metabolic Diseases | 1 | 2009 | 681 | 0.050 |
Why?
|
Program Evaluation | 5 | 2010 | 2491 | 0.050 |
Why?
|
Databases, Factual | 1 | 2018 | 7927 | 0.050 |
Why?
|
Hospital Costs | 1 | 2009 | 949 | 0.050 |
Why?
|
Arginine | 1 | 2006 | 932 | 0.050 |
Why?
|
Needs Assessment | 2 | 2005 | 1138 | 0.050 |
Why?
|
Bombesin | 1 | 2002 | 35 | 0.050 |
Why?
|
Prostate | 1 | 2010 | 1757 | 0.050 |
Why?
|
Base Sequence | 7 | 2017 | 12437 | 0.050 |
Why?
|
Tissue and Organ Procurement | 1 | 2010 | 943 | 0.050 |
Why?
|
Free Radical Scavengers | 1 | 2003 | 211 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5382 | 0.050 |
Why?
|
Treatment Outcome | 5 | 2019 | 64242 | 0.050 |
Why?
|
Prevalence | 1 | 2018 | 15640 | 0.050 |
Why?
|
Chromosome Mapping | 2 | 2021 | 4624 | 0.050 |
Why?
|
Early Diagnosis | 1 | 2005 | 1177 | 0.040 |
Why?
|
Age Factors | 5 | 2012 | 18326 | 0.040 |
Why?
|
Child, Preschool | 3 | 2024 | 42045 | 0.040 |
Why?
|
Patient Selection | 2 | 2018 | 4235 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2013 | 15781 | 0.040 |
Why?
|
Longitudinal Studies | 4 | 2020 | 14473 | 0.040 |
Why?
|
Erythema | 1 | 2021 | 262 | 0.040 |
Why?
|
Abdominal Wall | 1 | 2021 | 166 | 0.040 |
Why?
|
Clinical Protocols | 1 | 2005 | 1436 | 0.040 |
Why?
|
Sensitivity and Specificity | 6 | 2016 | 14637 | 0.040 |
Why?
|
Quality Improvement | 1 | 2014 | 3793 | 0.040 |
Why?
|
Follow-Up Studies | 6 | 2010 | 39020 | 0.040 |
Why?
|
Primary Health Care | 3 | 2010 | 4652 | 0.040 |
Why?
|
Membrane Proteins | 2 | 1993 | 7840 | 0.040 |
Why?
|
Attitude to Health | 3 | 2018 | 2024 | 0.040 |
Why?
|
Child Health Services | 1 | 2003 | 644 | 0.040 |
Why?
|
Quality of Life | 1 | 2019 | 13263 | 0.040 |
Why?
|
Pilot Projects | 4 | 2021 | 8550 | 0.040 |
Why?
|
Costs and Cost Analysis | 1 | 2003 | 1668 | 0.040 |
Why?
|
Heterozygote | 3 | 2019 | 2797 | 0.040 |
Why?
|
Radiography | 2 | 2021 | 6956 | 0.040 |
Why?
|
Exons | 2 | 1996 | 2392 | 0.040 |
Why?
|
Mutation, Missense | 1 | 2006 | 2564 | 0.040 |
Why?
|
Aging | 1 | 2016 | 8654 | 0.040 |
Why?
|
Brain | 3 | 2019 | 26952 | 0.040 |
Why?
|
Incidence | 2 | 2012 | 21217 | 0.030 |
Why?
|
Area Under Curve | 1 | 2021 | 1632 | 0.030 |
Why?
|
Parent-Child Relations | 1 | 2021 | 759 | 0.030 |
Why?
|
Infant, Low Birth Weight | 2 | 2000 | 858 | 0.030 |
Why?
|
Genomic Structural Variation | 1 | 2017 | 63 | 0.030 |
Why?
|
Reproducibility of Results | 4 | 2020 | 20037 | 0.030 |
Why?
|
Telephone | 1 | 2020 | 625 | 0.030 |
Why?
|
Time Factors | 6 | 2012 | 39811 | 0.030 |
Why?
|
Hyaline Membrane Disease | 2 | 1987 | 19 | 0.030 |
Why?
|
Genetic Research | 1 | 2017 | 171 | 0.030 |
Why?
|
Genetic Variation | 3 | 2019 | 6549 | 0.030 |
Why?
|
Cystic Adenomatoid Malformation of Lung, Congenital | 1 | 1995 | 41 | 0.030 |
Why?
|
Dandy-Walker Syndrome | 1 | 1995 | 45 | 0.030 |
Why?
|
Bronchopulmonary Sequestration | 1 | 1995 | 43 | 0.030 |
Why?
|
Adult | 12 | 2022 | 219725 | 0.030 |
Why?
|
Linear Models | 1 | 2005 | 5856 | 0.030 |
Why?
|
Health Status | 2 | 2009 | 4066 | 0.030 |
Why?
|
Arachnoid Cysts | 1 | 1995 | 61 | 0.030 |
Why?
|
Abdomen | 1 | 2021 | 1126 | 0.030 |
Why?
|
Referral and Consultation | 2 | 2005 | 3579 | 0.030 |
Why?
|
Analysis of Variance | 3 | 2012 | 6230 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2024 | 1870 | 0.030 |
Why?
|
Pharmacogenetics | 1 | 2019 | 675 | 0.030 |
Why?
|
Duodenal Obstruction | 1 | 1994 | 23 | 0.030 |
Why?
|
Practice Guidelines as Topic | 2 | 2017 | 7366 | 0.030 |
Why?
|
RNA, Messenger | 3 | 1999 | 12761 | 0.030 |
Why?
|
Forced Expiratory Volume | 1 | 1999 | 1806 | 0.030 |
Why?
|
Diffusion | 1 | 2016 | 812 | 0.030 |
Why?
|
Alternative Splicing | 1 | 1999 | 1091 | 0.030 |
Why?
|
Intensive Care Units, Neonatal | 2 | 2017 | 833 | 0.030 |
Why?
|
RNA Splicing | 1 | 2018 | 913 | 0.030 |
Why?
|
Antibodies, Bacterial | 1 | 1999 | 1469 | 0.030 |
Why?
|
United States | 3 | 2017 | 71902 | 0.030 |
Why?
|
Molecular Sequence Data | 5 | 1993 | 17615 | 0.030 |
Why?
|
Health Policy | 1 | 2005 | 2674 | 0.030 |
Why?
|
Limulus Test | 1 | 2012 | 19 | 0.030 |
Why?
|
Motivation | 1 | 2022 | 1996 | 0.030 |
Why?
|
Decision Making | 2 | 2022 | 3909 | 0.030 |
Why?
|
Tracheoesophageal Fistula | 1 | 1994 | 131 | 0.030 |
Why?
|
Feasibility Studies | 3 | 2016 | 5194 | 0.030 |
Why?
|
Family | 2 | 2018 | 3188 | 0.030 |
Why?
|
Models, Organizational | 2 | 2005 | 546 | 0.020 |
Why?
|
Informed Consent | 1 | 2018 | 1003 | 0.020 |
Why?
|
Proteome | 1 | 2022 | 1852 | 0.020 |
Why?
|
Introns | 2 | 1992 | 978 | 0.020 |
Why?
|
Caregivers | 1 | 2003 | 2224 | 0.020 |
Why?
|
Prospective Studies | 7 | 2019 | 54092 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2001 | 2144 | 0.020 |
Why?
|
Anastomosis, Surgical | 1 | 1995 | 979 | 0.020 |
Why?
|
Embryonic and Fetal Development | 1 | 1992 | 420 | 0.020 |
Why?
|
Esophageal Atresia | 1 | 1994 | 217 | 0.020 |
Why?
|
Communication | 1 | 2005 | 3841 | 0.020 |
Why?
|
Fetal Heart | 1 | 1992 | 281 | 0.020 |
Why?
|
Mouth Mucosa | 1 | 1993 | 426 | 0.020 |
Why?
|
Cell-Free System | 1 | 1990 | 340 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2017 | 1736 | 0.020 |
Why?
|
Gram-Negative Aerobic Rods and Cocci | 1 | 2009 | 1 | 0.020 |
Why?
|
DNA | 3 | 2011 | 7200 | 0.020 |
Why?
|
Basal Ganglia | 1 | 1992 | 553 | 0.020 |
Why?
|
Gram-Positive Cocci | 1 | 2009 | 8 | 0.020 |
Why?
|
Case-Control Studies | 3 | 2009 | 22022 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2016 | 2357 | 0.020 |
Why?
|
Workflow | 1 | 2014 | 850 | 0.020 |
Why?
|
Pancreas | 1 | 1996 | 1676 | 0.020 |
Why?
|
Persistent Fetal Circulation Syndrome | 1 | 1989 | 80 | 0.020 |
Why?
|
Aftercare | 2 | 2005 | 909 | 0.020 |
Why?
|
Infant Formula | 1 | 2010 | 193 | 0.020 |
Why?
|
Neuropsychology | 1 | 2009 | 107 | 0.020 |
Why?
|
Neurophysiology | 1 | 2009 | 144 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3809 | 0.020 |
Why?
|
Nutritional Requirements | 1 | 2009 | 275 | 0.020 |
Why?
|
Molecular Weight | 1 | 1990 | 2185 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 1975 | 1293 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 1742 | 0.020 |
Why?
|
Milk | 1 | 2010 | 443 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2019 | 2782 | 0.020 |
Why?
|
Cattle | 2 | 2010 | 3846 | 0.020 |
Why?
|
Endocrine Disruptors | 1 | 2010 | 263 | 0.020 |
Why?
|
Glycosylation | 1 | 1990 | 1096 | 0.020 |
Why?
|
Child | 3 | 2022 | 79782 | 0.020 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2009 | 354 | 0.020 |
Why?
|
Standard of Care | 1 | 2010 | 550 | 0.020 |
Why?
|
Thalamus | 1 | 1992 | 1040 | 0.020 |
Why?
|
Milk, Human | 1 | 2010 | 483 | 0.020 |
Why?
|
Cytomegalovirus Infections | 1 | 1992 | 831 | 0.020 |
Why?
|
Placebos | 2 | 2003 | 1661 | 0.020 |
Why?
|
Toll-Like Receptor 4 | 1 | 2009 | 576 | 0.020 |
Why?
|
Mandatory Testing | 1 | 2005 | 23 | 0.020 |
Why?
|
Anthropometry | 1 | 2010 | 1347 | 0.020 |
Why?
|
Image Enhancement | 1 | 2016 | 2880 | 0.020 |
Why?
|
Parental Consent | 1 | 2005 | 63 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 2646 | 0.020 |
Why?
|
Health Care Costs | 1 | 2018 | 3234 | 0.020 |
Why?
|
Physician Executives | 1 | 2005 | 133 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2010 | 25924 | 0.010 |
Why?
|
Cost-Benefit Analysis | 2 | 2009 | 5483 | 0.010 |
Why?
|
Pregnancy Outcome | 2 | 2010 | 2904 | 0.010 |
Why?
|
Blood Proteins | 1 | 2009 | 1173 | 0.010 |
Why?
|
Cost Savings | 1 | 2009 | 913 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 1993 | 6070 | 0.010 |
Why?
|
Syndrome | 1 | 2009 | 3261 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2016 | 3338 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2009 | 2922 | 0.010 |
Why?
|
Intestines | 1 | 1992 | 1907 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1990 | 2106 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2009 | 10749 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2009 | 1825 | 0.010 |
Why?
|
Computational Biology | 1 | 2014 | 3501 | 0.010 |
Why?
|
Intubation, Intratracheal | 2 | 2003 | 1327 | 0.010 |
Why?
|
Amino Acid Sequence | 2 | 1992 | 13442 | 0.010 |
Why?
|
Health Care Rationing | 1 | 2005 | 434 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2010 | 1878 | 0.010 |
Why?
|
Anti-Infective Agents | 1 | 2009 | 981 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2012 | 5861 | 0.010 |
Why?
|
Policy Making | 1 | 2005 | 538 | 0.010 |
Why?
|
Developmental Disabilities | 1 | 2010 | 1504 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 1992 | 4282 | 0.010 |
Why?
|
Models, Psychological | 1 | 2005 | 829 | 0.010 |
Why?
|
Regression Analysis | 1 | 2010 | 6337 | 0.010 |
Why?
|
Homeostasis | 1 | 1992 | 3299 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2009 | 4845 | 0.010 |
Why?
|
Electrolytes | 1 | 2001 | 274 | 0.010 |
Why?
|
Sweating | 1 | 2001 | 154 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2005 | 3970 | 0.010 |
Why?
|
Drug Costs | 1 | 2009 | 1179 | 0.010 |
Why?
|
Barotrauma | 1 | 2000 | 39 | 0.010 |
Why?
|
Quality Indicators, Health Care | 1 | 2010 | 1791 | 0.010 |
Why?
|
Drug Evaluation | 1 | 2001 | 642 | 0.010 |
Why?
|
Echocardiography | 1 | 1992 | 4963 | 0.010 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2000 | 186 | 0.010 |
Why?
|
Sex Factors | 1 | 2013 | 10495 | 0.010 |
Why?
|
Sepsis | 1 | 2013 | 2579 | 0.010 |
Why?
|
Demography | 1 | 2003 | 1645 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2687 | 0.010 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 1989 | 1452 | 0.010 |
Why?
|
Pulmonary Alveoli | 2 | 1984 | 651 | 0.010 |
Why?
|
New York | 1 | 2000 | 873 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2017 | 12601 | 0.010 |
Why?
|
Cytokines | 1 | 2012 | 7336 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2010 | 7024 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 2000 | 1153 | 0.010 |
Why?
|
Nutritional Status | 1 | 2005 | 1606 | 0.010 |
Why?
|
Electroencephalography | 1 | 2012 | 6187 | 0.010 |
Why?
|
Esophageal Cyst | 1 | 1995 | 13 | 0.010 |
Why?
|
Polyhydramnios | 1 | 1995 | 41 | 0.010 |
Why?
|
Social Support | 1 | 2005 | 2152 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2000 | 1526 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2009 | 10135 | 0.010 |
Why?
|
Atmosphere Exposure Chambers | 1 | 1975 | 51 | 0.010 |
Why?
|
Mediastinal Diseases | 1 | 1995 | 91 | 0.010 |
Why?
|
Cranial Fossa, Posterior | 1 | 1995 | 135 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2005 | 2629 | 0.010 |
Why?
|
Air | 1 | 1975 | 186 | 0.010 |
Why?
|
Animals | 6 | 2010 | 167718 | 0.010 |
Why?
|
Karyotyping | 1 | 1995 | 1171 | 0.010 |
Why?
|
Amniotic Fluid | 1 | 1995 | 378 | 0.010 |
Why?
|
Thoracic Neoplasms | 1 | 1995 | 265 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2005 | 3670 | 0.010 |
Why?
|
Antilymphocyte Serum | 1 | 1975 | 482 | 0.010 |
Why?
|
Cheek | 1 | 1993 | 65 | 0.010 |
Why?
|
Complement C1s | 1 | 1992 | 11 | 0.010 |
Why?
|
Safety | 1 | 1997 | 1147 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 4565 | 0.010 |
Why?
|
Threonine | 1 | 1992 | 270 | 0.010 |
Why?
|
Pregnancy Trimester, Second | 1 | 1994 | 731 | 0.010 |
Why?
|
Kallikreins | 1 | 1992 | 218 | 0.010 |
Why?
|
Colon | 1 | 1999 | 1788 | 0.010 |
Why?
|
Glutamates | 1 | 1992 | 389 | 0.010 |
Why?
|
Adolescent | 1 | 1999 | 87819 | 0.010 |
Why?
|
Valine | 1 | 1992 | 408 | 0.010 |
Why?
|
Dilatation, Pathologic | 1 | 1992 | 527 | 0.010 |
Why?
|
Abortion, Spontaneous | 1 | 1995 | 530 | 0.010 |
Why?
|
Codon | 1 | 1992 | 601 | 0.010 |
Why?
|
Maternal-Fetal Exchange | 1 | 1992 | 462 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2003 | 12047 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1997 | 3799 | 0.010 |
Why?
|
Alanine | 1 | 1992 | 603 | 0.010 |
Why?
|
Taq Polymerase | 1 | 1989 | 20 | 0.010 |
Why?
|
Blotting, Western | 1 | 1997 | 5031 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 1992 | 1229 | 0.010 |
Why?
|
Antibodies | 1 | 1997 | 2420 | 0.010 |
Why?
|
Single-Blind Method | 1 | 1993 | 1567 | 0.010 |
Why?
|
Blotting, Southern | 1 | 1989 | 777 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 2 | 2012 | 36270 | 0.000 |
Why?
|
Specimen Handling | 1 | 1993 | 702 | 0.000 |
Why?
|
Blotting, Northern | 1 | 1989 | 1543 | 0.000 |
Why?
|
Neuroblastoma | 1 | 1995 | 1247 | 0.000 |
Why?
|
Aged | 1 | 2019 | 167890 | 0.000 |
Why?
|
Respiratory Insufficiency | 1 | 1995 | 1230 | 0.000 |
Why?
|
Young Adult | 1 | 2013 | 58755 | 0.000 |
Why?
|
Glutamic Acid | 1 | 1992 | 1167 | 0.000 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 1989 | 489 | 0.000 |
Why?
|
Chromosome Aberrations | 1 | 1992 | 1764 | 0.000 |
Why?
|
Pulmonary Gas Exchange | 1 | 1987 | 378 | 0.000 |
Why?
|
Phosphatidylglycerols | 1 | 1984 | 34 | 0.000 |
Why?
|
Gene Amplification | 1 | 1989 | 1086 | 0.000 |
Why?
|
Transfection | 1 | 1992 | 5777 | 0.000 |
Why?
|
Brain Diseases | 1 | 1992 | 1541 | 0.000 |
Why?
|
Ductus Arteriosus, Patent | 1 | 1984 | 218 | 0.000 |
Why?
|
Random Allocation | 1 | 1987 | 2388 | 0.000 |
Why?
|
Fibroblasts | 1 | 1992 | 4087 | 0.000 |
Why?
|
Pregnancy Complications, Infectious | 1 | 1992 | 2125 | 0.000 |
Why?
|
Clinical Trials as Topic | 2 | 1987 | 7982 | 0.000 |
Why?
|
Prognosis | 1 | 2000 | 29488 | 0.000 |
Why?
|
Cell Line | 1 | 1992 | 15587 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1992 | 18936 | 0.000 |
Why?
|
Mice | 1 | 1975 | 81066 | 0.000 |
Why?
|